Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immunochemical studies on
Shigella sonnei
and serotype 6 Shigella flexneri 0 antigens (lipopolysaccharides) and enterobacterial common antigen (ECA) isolated from
Shigella sonnei
were carried out. Oligosaccharide structure of 0-specific chain of serotype 6 Shigella fiexneri
lipopolysaccharide
was defined and beta-L-rhamnosyl-1,3-N-acetyl-D-galactosamin as immunodeterminant of type VI specificity was recognized. The structures of core regions of lipopolysaccharides isolated from R mutants of both Shigella subgroups were established. On the base of the serological and structural results it has been suggested that these core regions are identical and very close to RI core structure of E. coli C. The effective method of isolation and purification of enterobacterial common antigen from
Shigella sonnei
was elaborated and its immunological properties as well as chemical character defined.
...
PMID:Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen. 8 36
Escherichia coli O127:B8
lipopolysaccharide
(
LPS
), prepared by the Westphal procedure, caused a marked decrease in the activities of mitochondrial malate dehydrogenase, succinate dehydrogenase, and adenylate kinase in African green monkey kidney (Vero) cells and primary cultures of mouse liver cells within 2 h after exposure to 10 micrograms of
LPS
/ml of culture medium. These three enzyme activities leaked into the supernatant fraction, and cytochrome oxidase activity was lost from the mouse liver mitochondrial particulate fraction within 45 min after exposure to 10 micrograms of
LPS
/mg of protein. Loss malate dehydrogenase activity from isolated mitochondria was also accelerated by
LPS
from E. coli O26:B6 (Boivin preparation) or Salmonella typhosa O901 (Westphal preparation), and by lipid A from Salmonella minnesota or
Shigella sonnei
. In addition,
LPS
and lipid A inhibited state 3 respiration by isolated mitochondria with attendant loss of respiratory control, but adenosine 5'-diphosphate/O ratios were relatively unchanged. Impaired mitochondrial function is an early event after exposure to biologically relevant amounts of
LPS
or lipid A.
...
PMID:Action of bacterial endotoxin and lipid A on mitochondrial enzyme activities of cells in culture and subcellular fractions. 11 91
Immunogenic, antigenic and toxic properties of free endotoxin isolated from culture media of
Shigella sonnei
, phase I, was studied. Experiments with mice showed that free endotoxin is about 3--4 times more active immunogenically and twice as toxic as cellular
lipopolysaccharide
. On the other hand, the antigenic activity of free endotoxin was about equal to that of
lipopolysaccharide
. In addition, free endotoxin had a common property characteristic for endotoxins isolated from Gram-negative bacteria, namely it stimulated the immunologic response to unrelated antigens, e.g. antigens of sheep red blood cells.
...
PMID:Comparative studies on the immunologic properties of free endotoxin and lipopolysaccharide from Shigella sonnei. 32 99
Comparative chemical analysis (methylation, gas chromatography/mass spectrometry, periodate oxidation, etc.) of the lipopolysaccharides and degraded polysaccharides derived from
Shigella sonnei
phase I, phase II and galactose-deficient R mutants revealed a structure as shown: (formula: see text) 3-Deoxy-D-manno-octulosonic acid (dOclA) as an immunodeterminant was observed in the passive hemolysis inhibition test by (a) selective inhibition of the phase II system by dOclA; (b) the kinetics of the change of serological activity during mild acid treatment: 1% acetic acid abolished serological activity; (c) a lack of activity in galactose-less R mutants and reactivity with Re mutants including Salmonella minnesota Re. An enhanced sensitivity of phase II
lipopolysaccharide
to galactose oxidase after prolonged treatment with 1% acetic acid suggests that dOclA is linked to C-6 of the terminal or subterminal galactose. dOclA as immunodeterminant could explain some different polysaccharide structures described for Escherichia coli R1 core.
...
PMID:Structure of the hexose region of Shigella sonnei phase II lipopolysaccharide with 3-deoxy-D-manno-octulosonic acid as possible immunodeterminant and its relation to Escherichia coli R1 core. 35 97
Interferon-inducing capacity of uniform salts of
Shigella sonnei
lipopolysaccharide
(
LPS
), its polysaccharide component and lipid A were compared. Low-molecular-weight triethylamine and ethanolamine salt forms of the
lipopolysaccharide
were most active in interferon production. It was confirmed that lipid part of
LPS
is responsible for interferon-inducing activity.
...
PMID:Interferon induction in mice by uniform salt forms of Shigella sonnei lipopolysaccharide and its components. 37 82
An improved quantitative micromethod is described for the assay of antigenically active bacterial lipopolysaccharides and their immunodeterminant oligosaccharides. The method which is capable of measuring antigens in nanogram quantities yields the same sensitivity as the microcomplement fixation without the limitations of this method. The use of the method was demonstrated on
Shigella sonnei
phase 1 and phase ii
lipopolysaccharide
antigens and immunodeterminants.
...
PMID:Passive hemolysis inhibition test for quantitation of serologically active polysaccharides and oligosaccharides in micro amounts. 79 88
The genetic information to synthesize the S-specific region of
Shigella sonnei
phase I
lipopolysaccharide
(
LPS
) is localized on a 180 kb plasmid which is lost quite readily. A recombinant plasmid derivative remaining stable in the bacteria was shown to determine the S-specific region of the
LPS
which is completely identical with that of a S. sonnei phase I strain following transfer in Escherichia coli K-12. However, the length control in polysaccharide biosynthesis is lost at least partially.
...
PMID:Characterization of a lipopolysaccharide encoded by a recombinant Shigella sonnei plasmid in Escherichia coli K-12. 128 53
O-specific-polysaccharide and core oligosaccharide were isolated from Citrobacter strain PCM 1487
lipopolysaccharide
and purified. The polysaccharide was selectively devoid of 4-deoxy-D-arabinohexose residues. Covalent conjugates of the modified O-specific polysaccharide and of the core oligosaccharide with tetanus toxoid were prepared. Immunochemical characterization of these conjugates proved that they are strong immunogens. Using monospecific rabbit antisera raised against the conjugates, the antigenic relationships between lipopolysaccharides of various strains of Citrobacter,
Shigella sonnei
, and Shigella flexneri were studied by quantitative microprecipitin and quantitative microprecipitin inhibition and immunoblotting tests.
...
PMID:Immunochemical characterization of Citrobacter strain PCM 1487 O-specific polysaccharide- and core oligosaccharide-protein conjugates. 137 31
We conducted a prospective, community-based study of healthy breast-fed Mexican infants to determine the protective effects of anti-Shigella secretory IgA antibodies in milk. Milk samples were collected monthly, and stool culture specimens were obtained weekly and at the time of episodes of diarrhea. Nineteen breast-fed infants were found to have Shigella flexneri, Shigella boydii, or
Shigella sonnei
in stool samples. Ages of the 10 infants with symptomatic infection and the nine with asymptomatic infection did not differ significantly. Milk samples collected up to 12 weeks before infection were evaluated by enzyme-linked immunosorbent assay for secretory IgA antibodies against lipopolysaccharides of S. flexneri, S. boydii serotype 2, S. sonnei, and virulence plasmid-associated antigens. The geometric mean titers of anti-Shigella antibodies to virulence plasmid-associated antigens in milk received before infection were eightfold higher in infants who remained well than in those in whom diarrhea developed. The significance of milk secretory IgA directed against
lipopolysaccharide
was less clear. We conclude that human milk protects infants against symptomatic shigella infection when it contains high concentrations of secretory IgA against virulence plasmid-associated antigens.
...
PMID:Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants. 144 44
The appearance of antigen-specific immunoglobulin A (IgA) antibody-secreting cells (ASCs) following natural infection with
Shigella sonnei
during a common-source outbreak caused by this organism was evaluated in a modified enzyme-linked immunosorbent assay (ELISPOT). A mean IgA ASC value of 2,131.6/10(6) cells against homologous S. sonnei
lipopolysaccharide
(
LPS
) was detected in blood samples obtained from patients with bacteriologically proven S. sonnei shigellosis 5 and 10 days after the onset of disease. In the same blood samples, the level of ASC measured against heterologous antigen (Shigella flexneri serotype 2a
LPS
) was significantly lower than that of the homologous antigen (mean value, 33.12/10(6) cells). Furthermore, the mean number of activated B cells that secreted anti-S. sonnei
LPS
antibodies was significantly higher among patients with S. sonnei shigellosis than it was among patients with non-Shigella diarrhea (2.5/10(6) cells; standard error, 1.0) and healthy subjects (5.1/10(6) cells; standard error, 2.3) (P less than 0.05). The anti-
LPS
IgA ASC activity was easily detected within 5 days of the onset of disease, a point at which the levels of anti-S. sonnei
LPS
IgG and even IgA antibodies were hardly detectable in serum.
...
PMID:Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei. 150 May 27
1
2
3
4
5
6
7
8
9
Next >>